Castle Biosciences (CSTL) EBIT Growth (3y) (2021 - 2026)
Castle Biosciences (CSTL) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 9.77% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -1.04% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 12.85% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 1.37% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -1.16% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 12.23% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 68.50% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 3.10% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 9.67% |
| 10 | Castle Biosciences | 919.57 Mn | 652.76 Mn | 79.85 Mn | 47.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.45% |
| Mar 31, 2026 | 16.42% |
| Dec 31, 2025 | 44.86% |
| Sep 30, 2025 | 31.89% |
| Jun 30, 2025 | -2.30% |
| Mar 31, 2025 | -4.44% |
| Dec 31, 2024 | 31.37% |
| Sep 30, 2024 | 34.44% |
| Jun 30, 2024 | 36.96% |
| Mar 31, 2024 | -8.49% |
| Dec 31, 2023 | -23.12% |
| Sep 30, 2023 | -35.20% |
| Jun 30, 2023 | -220.11% |
| Mar 31, 2023 | -218.88% |
| Dec 31, 2022 | -120.62% |
| Sep 30, 2022 | -90.03% |
| Jun 30, 2022 | -104.33% |
| Mar 31, 2022 | -323.84% |
| Dec 31, 2021 | -73.05% |
| Sep 30, 2021 | -60.61% |